During the past decade, Hôpital Européen conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 7 clinical trials were completed, i.e. on average, 8.1% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 6 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Européen" #1 sponsor was "Hôpital Européen Marseille" with 14 trials, followed by "Federation Francophone de Cancerologie Digestive" with 9 trials sponsored, "UNICANCER" with 7 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 5 trials sponsored and "Hospital St. Joseph, Marseille, France" with 5 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Européen" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "UNICANCER" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Européen" are "Systemic Lupus Erythematosus" (5 trials), "Metastatic Pancreatic Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "HIV Infections" (3 trials) and "HIV-1 Infection" (3 trials). Many other conditions were trialed in "Hôpital Européen" in a lesser frequency.

Most popular intervention types in "Hôpital Européen" are "Drug" (48 trials), "Other" (27 trials), "Device" (7 trials), "Procedure" (5 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Paclitaxel" (4 trials), "Gemcitabine" (3 trials), "Administration of the IPREA3 questionnaire" (2 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Européen" are 86 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Européen". 2 are not yet recruiting, 31 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Hôpital Européen, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Européen, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 25 trials that are defined as “Not Applicable".

Hôpital Européen has several departments that took part in Clinical trials: "Hopital européen de Marseille; Neurologie" - 2 trials